Relevant conflicts of interest/financial disclosures: Dr. Reilmann provided consulting services, advisory board functions, clinical trial services, quantitative motor analyses, and/or lectures for Novartis, Teva, Siena Bitoech, Neurosearch Inc., Medivation/Pfizer, Lundbeck, Ipsen, Wyeth, ISIS Pharma, Link Medicine, Prana Biotechnology, the Cure Huntington's Disease Initiative Foundation, MEDA, Temmler Pharma, and AOP Orphan Pharmaceuticals AG. He serves on the Advisory Board of the “Jacques and Gloria Gossweiler Foundation” and has several responsibilities in the European Huntington's Disease Network (member of the “Executive Committee” and the “Clinical Trials Task Force”, Lead Facilitator of the Neuroprotective Therapy and Motor Phenotype Working Groups) and serves as Global Coordinating Principle Investigator of clinical trials. Dr. Reilmann received grant support from the High-Q-Foundation, the Cure Huntington's Disease Initiative Foundation (CHDI), the Deutsche Forschungsgemeinschaft (DFG), the European Union (EU-FP7 program) and the European Huntington's Disease Network (EHDN).
The pridopidine paradox in Huntington's disease
Version of Record online: 11 JUL 2013
© 2013 International Parkinson and Movement Disorder Society
Volume 28, Issue 10, pages 1321–1324, September 2013
How to Cite
Reilmann, R. (2013), The pridopidine paradox in Huntington's disease. Mov. Disord., 28: 1321–1324. doi: 10.1002/mds.25559
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 23 SEP 2013
- Version of Record online: 11 JUL 2013
- Manuscript Accepted: 10 MAY 2013
- Manuscript Revised: 5 MAY 2013
- Manuscript Received: 20 FEB 2013
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.